SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · Three corporate insiders at United Therapeutics, including CEO Martine…

UNITED THERAPEUTICS Corp · CLUSTER filed Apr 2, 2026 at 16:36 ET

At the news

MIXEDIMPACT 5/10

CLUSTER filed Apr 2, 2026 at 16:36 ET

Three corporate insiders at United Therapeutics, including CEO Martine Rothblatt and CFO James Edgemond, conducted open-market sales totaling $1.08 million over a 7-day window, following a series of derivative exercises. The sales are modest in absolute value but involve key executives, raising questions about intent despite no clear signs of distress.

  • CEO Martine Rothblatt sold 1,300 shares for $725K in open-market transactions across multiple days (April 6–9, 2026).
  • CFO James Edgemond sold 680 shares for $388K, including a $322K sale on April 9.
  • EVP & General Counsel Paul Mahon sold 514 shares for $288K on April 2.
  • Total open-market sales: $1.08M, representing 0.0043% of the company's $25.2B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access